These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11217929)

  • 21. Vitreous penetration of orally administered gatifloxacin in humans.
    Hariprasad SM; Mieler WF; Holz ER
    Trans Am Ophthalmol Soc; 2002; 100():153-9. PubMed ID: 12545689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human vitreous distribution of linezolid after a single oral dose.
    Ciulla TA; Comer GM; Peloquin C; Wheeler J
    Retina; 2005; 25(5):619-24. PubMed ID: 16077360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative population pharmacokinetic analysis for methylprednisolone following multiple dosing of two prodrugs in patients with acute asthma.
    Parker TJ; Daley-Yates PT; Wood SA
    Br J Clin Pharmacol; 1997 Jun; 43(6):589-92. PubMed ID: 9205818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans.
    Hariprasad SM; Mieler WF; Holz ER; Gao H; Kim JE; Chi J; Prince RA
    Arch Ophthalmol; 2004 Jan; 122(1):42-7. PubMed ID: 14718293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative pharmacokinetics of methylprednisolone phosphate and hemisuccinate in high doses.
    Möllmann H; Rohdewald P; Barth J; Möllmann C; Verho M; Derendorf H
    Pharm Res; 1988 Aug; 5(8):509-13. PubMed ID: 3072558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levels of pentosidine in the vitreous of eyes with proliferative diabetic retinopathy, proliferative vitreoretinopathy and retinal detachment.
    Tomé CC; De Rojas Silva MV; Rodríguez-García J; Rodríguez-Segade S; Sánchez-Salorio M
    Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1272-6. PubMed ID: 15947940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical and systemic absorption in delivery of dexamethasone to the anterior and posterior segments of the eye.
    Sigurdsson HH; Konráethsdóttir F; Loftsson T; Stefánsson E
    Acta Ophthalmol Scand; 2007 Sep; 85(6):598-602. PubMed ID: 17645424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of sex steroid concentration levels in the vitreous and serum of patients with vitreoretinal diseases.
    Nishikawa Y; Morishita S; Horie T; Fukumoto M; Sato T; Kida T; Oku H; Sugasawa J; Ikeda T; Nakamura K
    PLoS One; 2017; 12(7):e0180933. PubMed ID: 28704441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes.
    Chin HS; Park TS; Moon YS; Oh JH
    Retina; 2005; 25(5):556-60. PubMed ID: 16077349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitreous and aqueous penetration of orally administered gatifloxacin in humans.
    Hariprasad SM; Mieler WF; Holz ER
    Arch Ophthalmol; 2003 Mar; 121(3):345-50. PubMed ID: 12617704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitreous and aqueous penetration of orally administered moxifloxacin in humans.
    Hariprasad SM; Shah GK; Mieler WF; Feiner L; Blinder KJ; Holekamp NM; Gao H; Prince RA
    Arch Ophthalmol; 2006 Feb; 124(2):178-82. PubMed ID: 16476886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population pharmacokinetics of methylprednisolone in accident victims with spinal cord injury.
    Barth J; Winkler J; Schumann R; Nagaraja NV; Madabushi R; Balbach S; Derendorf H; Möllmann H; Möllenhoff G
    Int J Clin Pharmacol Ther; 2004 Sep; 42(9):504-11. PubMed ID: 15487809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant.
    Chang-Lin JE; Attar M; Acheampong AA; Robinson MR; Whitcup SM; Kuppermann BD; Welty D
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):80-6. PubMed ID: 20702826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose intravenous pulse methylprednisolone hemisuccinate in acute Behçet retinitis.
    Reed JB; Morse LS; Schwab IR
    Am J Ophthalmol; 1998 Mar; 125(3):409-11. PubMed ID: 9512170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitreous and Aqueous Penetration of Orally Administered Trimethoprim-Sulfamethoxazole Combination in Humans.
    Feiz V; Nijm L; Glickman RD; Morse LS; Telander DG; Park SS; Polage CR; Christiansen SM; Moshirfar M
    Cornea; 2013 Oct; 32(10):1315-20. PubMed ID: 23928948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ocular iontophoretic supplementation of intravenous foscarnet therapy.
    Yoshizumi MO; Roca JA; Lee DA; Lee G; Gomez I
    Am J Ophthalmol; 1996 Jul; 122(1):86-90. PubMed ID: 8659602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of hyaloid-retinal relationship during triamcinolone-assisted vitrectomy for primary rhegmatogenous retinal detachment.
    Sundar D; Takkar B; Venkatesh P; Chawla R; Temkar S; Azad SV; Vohra R
    Eur J Ophthalmol; 2018 Sep; 28(5):607-613. PubMed ID: 29569478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuous infusion of methylprednisolone via paediatric parenteral nutrition: a pharmacokinetic animal study.
    Gellis C; Sautou-Miranda V; Bleyzac N; Jarrige JF; Minet-Quinard R; Chopineau J
    Clin Nutr; 2007 Aug; 26(4):491-7. PubMed ID: 17442463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decrease in oral bioavailability of ciclosporin by intravenous pulse of methylprednisolone succinate in rats.
    Konishi H; Sumi M; Shibata N; Takada K; Minouchi T; Yamaji A
    J Pharm Pharmacol; 2004 Oct; 56(10):1259-66. PubMed ID: 15482640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Penetration of ofloxacin in human aqueous and vitreous humors following oral and topical administration.
    Cekic O; Batman C; Yasar U; Basci NE; Bozkurt A; Kayaalp SO
    Retina; 1998; 18(6):521-5. PubMed ID: 9869460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.